Using the excitation/inhibition ratio to optimize the classification of autism and schizophrenia.

Publication date: Jul 09, 2025

The excitation/inhibition (E/I) ratio has been shown to be imbalanced in individuals diagnosed with autism (AT) or schizophrenia (SZ), relative to neurotypically developed controls (TD). However, the degree of E/I imbalance overlap between SZ and AT has not been extensively compared. In this project, we used resting state fMRI data to estimate the E/I ratio via the Hurst (H) exponent. Our main objectives were (1) to quantify group differences in the E/I ratio between TD, AT, and SZ, (2) to assess the potential of the E/I ratio for differential diagnosis, and (3) to verify the replicability of our findings in an independently acquired dataset. For each participant, we computed the Hurst exponent (H), an indicator of the E/I ratio, from the time courses of 53 independent components. Using a random forest classifier (RF), we ran a classification analysis using the larger of the two datasets (exploratory dataset; 519 TD, 200 AT, 355 SZ) to determine which of the 53 H would yield the highest performance in classifying SZ and AT. Next, taking the ten most important H based on the exploratory dataset, in combination with phenotypic information collected in the replication dataset (55 TD, 30 AT, 39 SZ), we used RF to compare the classification performance using five feature sets: (a) H only; (b) Positive and Negative Syndrome Scale (PANSS) and the Autism Diagnostic Observation Schedule (ADOS) only; (c) PANSS, ADOS, Bermond-Vorst Alexithymia Questionnaire (BVAQ), Empathy Quotient (EQ), and IQ; (d) H, PANSS and ADOS; (e) H, PANSS, ADOS, BVAQ, EQ and IQ. Classification performance using H only was higher in the exploratory dataset (AUC = 84%) compared to the replication dataset (AUC = 72%). In the replication dataset, the highest classification performance was obtained when combining H with PANSS, ADOS, BVAQ, EQ and IQ (i. e., model e; AUC = 83%). These results illustrate the added value of E/I to typical phenotypic data in differentiating AT and SZ.

Open Access PDF

Concepts Keywords
Autism Adolescent
Empathy Adult
Forest Autistic Disorder
Psychiatry Brain
Td Diagnosis, Differential
Female
Humans
Magnetic Resonance Imaging
Male
Schizophrenia
Young Adult

Semantics

Type Source Name
disease MESH autism
disease MESH schizophrenia
drug DRUGBANK Ranitidine
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH Syndrome
disease MESH Alexithymia
disease MESH hallucinations
disease MESH delusions
disease MESH psychiatric diagnosis
disease MESH psychosis
drug DRUGBANK Coenzyme M
drug DRUGBANK Isoxaflutole
drug DRUGBANK gamma-Aminobutyric acid
drug DRUGBANK Bumetanide
drug DRUGBANK Chloride ion
drug DRUGBANK Arbaclofen
drug DRUGBANK Dopamine
disease MESH withdrawal symptoms
drug DRUGBANK Copper
disease MESH intellectual disability
disease MESH neurological disorders
disease MESH epilepsy
drug DRUGBANK Chlorpromazine
disease MESH anhedonia
drug DRUGBANK Albendazole

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *